SARS CoV 2 News and Research

RSS

Study highlights mental health benefits of COVID-19 vaccination

Findings indicate COVID-19 vaccination reduces mental health illness incidence, particularly among those with prior mental health issues and older adults.

26 Aug 2024

Mutation in SARS-CoV-2 spike protein enhances brain infection

Scientists have discovered a mutation in SARS-CoV-2, the virus that causes COVID-19, that plays a key role in its ability to infect the central nervous system.

23 Aug 2024

Virginia Tech leads national initiative to predict and prevent future pandemics

Viruses like SARS-CoV-2 don't respect boundaries, moving between species and continents and leaving destruction as they go. Beating the next pathogen with pandemic potential means getting good at crossing borders ourselves - between fields of study, between research universities, and between scientists and the wider community.

23 Aug 2024

Study reveals long COVID's wide impact on children's health

The kids were correct all along. In the most comprehensive national study since the onset of the COVID-19 pandemic, a team of researchers that includes a Rutgers-organized consortium of pediatric sites has concluded that long COVID symptoms in children are tangible, pervasive, wide ranging and clinically distinct within specific age groups.

22 Aug 2024

The lingering mental health effects of severe COVID-19

A new study that examined health data on 18 million people reveals a higher incidence of mental illnesses for up to a year following severe COVID-19 in unvaccinated people. Vaccination appeared to mitigate the adverse effects of COVID-19 on mental illnesses. The University of Bristol-led study, published in JAMA Psychiatry on August 21st, 2024, investigated associations of COVID-19 with mental illnesses according to time since diagnosis and vaccination status.

22 Aug 2024

Study reveals distinct long COVID patterns in children and adolescents

Scientists investigating long COVID in youth found similar but distinguishable patterns between school-age children (ages 6-11 years) and adolescents (ages 12-17 years) and identified their most common symptoms.

21 Aug 2024

New index identifies school-age children likely to have long COVID

A research team led by the National Institutes of Health's RECOVER Initiative and supported by its Clinical Science Core (CSC) at NYU Langone Health, has designed a new way to identify which school-age children and adolescents most likely have Long COVID.

21 Aug 2024

SwRI develops a unique technology to screen new DNA-targeting therapeutics

Southwest Research Institute (SwRI) has developed a unique technology to screen new DNA-targeting therapeutics designed to treat cancer and other diseases.

19 Aug 2024

Long COVID symptoms may stem from low cortisol and altered brain immune response

Proteins left behind by COVID-19 long after initial infection can cause cortisol levels in the brain to plummet, inflame the nervous system and prime its immune cells to hyper-react when another stressor arises, according to new animal research by University of Colorado Boulder scientists.

19 Aug 2024

New insights into COVID-19 spike protein offer hope for universal vaccines

A team led by Jose Onuchic at Rice University and Paul Whitford at Northeastern University, both researchers at the National Science Foundation Physics Frontiers Center at the Center for Theoretical Biological Physics (CTBP) at Rice, has made a discovery in the fight against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the virus responsible for COVID-19.

16 Aug 2024

Study reveals long COVID's impact on American workforce

A new Yale study finds that the effects of long COVID have caused many Americans to miss extensive work time, and that 14% of study participants reported not returning to work in the months after their infection.

16 Aug 2024

Infections drive brain volume loss and dementia risk by altering key immune proteins, study reveals

Severe infections are linked to increased brain atrophy, particularly in the temporal lobe, which may elevate dementia risk through immune-related proteins.

15 Aug 2024

Study finds no clinically useful biomarkers for long COVID in routine lab tests

Whether tests in current use were adequate to identify post-acute sequelae of SARS-CoV-2 (PASC).

14 Aug 2024

COVID-19 vaccine rollout phases linked to decreased anxiety and depression in US adults

The various COVID-19 vaccine rollout phases impacted the prevalence of depression and anxiety at the population level among adults in the country.

14 Aug 2024

Routine lab tests fail to identify reliable biomarkers for long COVID, study finds

Study found no reliable clinical biomarkers for diagnosing PASC (long COVID) from routine laboratory tests, despite minor differences in some measures between infected and non-infected individuals.

13 Aug 2024

New insights into the pharmacokinetics of remdesivir in treating SARS-CoV-2 in pregnant women

A new study provides important insights into the pharmacokinetics and safety of intravenous remdesivir in treating the SARS-CoV-2 coronavirus in pregnant women.

13 Aug 2024

Prioritizing older individuals for COVID-19 boosters yields best public health outcomes, study finds

Whether prioritizing older individuals for COVID-19 booster vaccinations consistently leads to optimal public health outcomes across diverse socio-economic settings.

13 Aug 2024

Long COVID's lasting toll: Economic losses, healthcare strain, and the urgent need for better global policies

Study reviews the impact of long COVID on individuals, health systems, and global economies, highlighting the need for a coordinated, patient-centered approach for future research and policy development.

12 Aug 2024

NIH study finds routine lab tests fall short in diagnosing long COVID

A National Institutes of Health (NIH)-supported study has found that routine lab tests may not be useful in making a long COVID diagnosis for people who have symptoms of the condition

12 Aug 2024

Study uncovers OLAH as key driver of fatal respiratory disease

Respiratory infections can be severe, even deadly, in some individuals, but not in others.

12 Aug 2024

SARS CoV 2 News and Research

Study highlights mental health benefits of COVID-19 vaccination

Mutation in SARS-CoV-2 spike protein enhances brain infection

Virginia Tech leads national initiative to predict and prevent future pandemics

Study reveals long COVID's wide impact on children's health

The lingering mental health effects of severe COVID-19

Study reveals distinct long COVID patterns in children and adolescents

New index identifies school-age children likely to have long COVID

SwRI develops a unique technology to screen new DNA-targeting therapeutics

Long COVID symptoms may stem from low cortisol and altered brain immune response

New insights into COVID-19 spike protein offer hope for universal vaccines

Study reveals long COVID's impact on American workforce

Infections drive brain volume loss and dementia risk by altering key immune proteins, study reveals

Study finds no clinically useful biomarkers for long COVID in routine lab tests

COVID-19 vaccine rollout phases linked to decreased anxiety and depression in US adults

Routine lab tests fail to identify reliable biomarkers for long COVID, study finds

New insights into the pharmacokinetics of remdesivir in treating SARS-CoV-2 in pregnant women

Prioritizing older individuals for COVID-19 boosters yields best public health outcomes, study finds

Long COVID's lasting toll: Economic losses, healthcare strain, and the urgent need for better global policies

NIH study finds routine lab tests fall short in diagnosing long COVID

Study uncovers OLAH as key driver of fatal respiratory disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News